GetTopicDetailResponse(id=37ea11264e47, topicName=CAR-T 細(xì)胞療法, introduction=CAR-T 細(xì)胞療法, content=null, image=null, comments=0, allHits=1105, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Mar 24 12:22:35 CST 2024, time=2024-03-24, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=436777, tagList=[TagDto(tagId=436777, tagName=CAR-T 細(xì)胞療法)], ipAttribution=上海, topicAdmin=0, lengthMark=null)
[GetTopicListResponse(id=2273249, encodeId=f1e022e324958, content=<a href='/topic/show?id=81c2e4343a9' target=_blank style='color:#2F92EE;'>#神經(jīng)毒性#</a> <a href='/topic/show?id=37ea11264e47' target=_blank style='color:#2F92EE;'>#CAR-T 細(xì)胞療法#</a>, objectTitle=CAR-T 細(xì)胞療法后的長期認(rèn)知障礙：機(jī)制、意義與研究新方向, objectType=article, longId=886540, objectId=90cf88654085, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240607/1717751463356_2570354.jpg, objectUrl=/article/show_article.do?id=90cf88654085, replyNumber=0, likeNumber=35, createdTime=2025-07-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=90cf88654085, moduleTitle=CAR-T 細(xì)胞療法后的長期認(rèn)知障礙：機(jī)制、意義與研究新方向, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=90cf88654085)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2269912, encodeId=a2aa22699122a, content=<a href='/topic/show?id=1507912e609' target=_blank style='color:#2F92EE;'>#認(rèn)知障礙#</a> <a href='/topic/show?id=37ea11264e47' target=_blank style='color:#2F92EE;'>#CAR-T 細(xì)胞療法#</a>, objectTitle=Cell：CAR-T療法引起神經(jīng)系統(tǒng)副作用的機(jī)制及破解法, objectType=article, longId=878487, objectId=6d888e848749, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240518/1716040796818_5579292.jpg, objectUrl=/article/show_article.do?id=6d888e848749, replyNumber=0, likeNumber=37, createdTime=2025-06-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6d888e848749, moduleTitle=Cell：CAR-T療法引起神經(jīng)系統(tǒng)副作用的機(jī)制及破解法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6d888e848749)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2218596, encodeId=938d22185969d, content=<a href='/topic/show?id=87369652f3' target=_blank style='color:#2F92EE;'>#IL-2#</a> <a href='/topic/show?id=bcbd384814' target=_blank style='color:#2F92EE;'>#B細(xì)胞成熟抗原#</a> <a href='/topic/show?id=37ea11264e47' target=_blank style='color:#2F92EE;'>#CAR-T 細(xì)胞療法#</a>, objectTitle=開啟CAR-T細(xì)胞療法持久戰(zhàn)力新時(shí)代！Nat Biotechnol：CAR-E可讓CAR-T細(xì)胞在體內(nèi)長時(shí)間存活，并阻止癌癥在CAR-T細(xì)胞治療后復(fù)發(fā), objectType=article, longId=837416, objectId=bdce83e4161d, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20240805/1722840912916_8827638.png, objectUrl=/article/show_article.do?id=bdce83e4161d, replyNumber=0, likeNumber=93, createdTime=2024-08-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195212, encodeId=4de42195212cf, content=<a href='/topic/show?id=01858406438' target=_blank style='color:#2F92EE;'>#膠質(zhì)母細(xì)胞瘤#</a> <a href='/topic/show?id=37ea11264e47' target=_blank style='color:#2F92EE;'>#CAR-T 細(xì)胞療法#</a> <a href='/topic/show?id=4c496569c8' target=_blank style='color:#2F92EE;'>#EGFR#</a> <a href='/topic/show?id=e61311190563' target=_blank style='color:#2F92EE;'>#IL13RΑ2#</a>, objectTitle=Nat Med：初步臨床試驗(yàn)表明鞘內(nèi)注射靶向EGFR和IL13Rα2的雙靶點(diǎn)CAR-T細(xì)胞有望治療復(fù)發(fā)性膠質(zhì)母細(xì)胞瘤, objectType=article, longId=817822, objectId=f49281e82214, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240323/1711193821858_2185383.png, objectUrl=/article/show_article.do?id=f49281e82214, replyNumber=0, likeNumber=115, createdTime=2024-03-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195007, encodeId=4922219500efe, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受體#</a> <a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a> <a href='/topic/show?id=37ea11264e47' target=_blank style='color:#2F92EE;'>#CAR-T 細(xì)胞療法#</a>, objectTitle=Blood：第二原發(fā)惡性腫瘤在CAR-T細(xì)胞治療后的不良事件中所占比例很小, objectType=article, longId=817810, objectId=094b81e810b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240323/1711176666289_2185383.png, objectUrl=/article/show_article.do?id=094b81e810b8, replyNumber=0, likeNumber=206, createdTime=2024-03-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-03-24發(fā)表于上海
